Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.
FRG-8813
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
We investigated the recurrence of ulcers in rats after treatment with FRG-8813, (±)-2-(furfurylsulfinyl)-N-[4- [4…
1999
1999
Lafutidine (CAS 118288-08-7, FRG-8813) is a novel histamine H2-receptor antagonist with gastroprotective activity. The aim of…
1996
1996
Certain chemical properties, which may determine the stimulatory actions of the new histamine H2 receptor antagonist, FRG-8813 (2…
Highly Cited
1995
Highly Cited
1995
FRG-8813 ((+/-)-2-(furfurylsulfinyl)-N-[4-[4-(piperidinomethyl)-2- pyridyl]oxy-(Z)-2-butenyl]acetamide) is a novel histamine H2…
1995
1995
The present study was conducted to investigate the histamine H2-receptor antagonistic property of FRG-8813 by using isolated…
1994
1994
It is not presently well understood whether the histamine H2 receptor antagonist has a function other than the inhibition of…
1994
1994
The effects of the anti-acid secretory agents, cimetidine (N-cyano-N'-methyl-N"-(2-([(5-methyl-1H-imidazol-4-yl)methyl]thio)ethyl…
Highly Cited
1993
Highly Cited
1993
FRG-8813, a new histamine H2 receptor antagonist, was examined for antisecretory effects and compared with famotidine and…
1992
1992
We examined the anti-ulcer effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and…
1992
1992
We examined the anti-ulcer effects of FRG-8813, a new-type histamine H2-receptor antagonist, in chronic ulcer models of rats and…